HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, July 5, 2002 (HealthDayNews) -- Inhaled insulin may soon offer an alternative to needles for people with diabetes, says a company developing the product.
Novo Nordisk, a Denmark-based company, has ongoing clinical trials to test the safety and effectiveness of an electronic pulmonary insulin system. They say it may be available in the United States and Europe within a few years.
This is the first electronic pulmonary insulin system currently being tested in clinical trials. It works by converting a special liquid insulin into aerosol particles, which are inhaled into the lungs.
An update on the system was presented recently at the 62nd Scientific Sessions of the American Diabetes Association (ADA).
The ADA says that of the more than 17 million Americans with diabetes, about 3.7 million have to take up to five insulin shots each day to control their disease.
The American Diabetes Association has more on inhaled insulin.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on June 15, 2022